Haesuk Park

2.4k total citations
108 papers, 1.7k citations indexed

About

Haesuk Park is a scholar working on Epidemiology, Hepatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Haesuk Park has authored 108 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Epidemiology, 31 papers in Hepatology and 22 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Haesuk Park's work include Hepatitis C virus research (26 papers), Liver Disease Diagnosis and Treatment (25 papers) and Liver Disease and Transplantation (11 papers). Haesuk Park is often cited by papers focused on Hepatitis C virus research (26 papers), Liver Disease Diagnosis and Treatment (25 papers) and Liver Disease and Transplantation (11 papers). Haesuk Park collaborates with scholars based in United States, South Korea and Pakistan. Haesuk Park's co-authors include Linda Henry, Zobair M. Younossi, Ayoade Adeyemi, Karen L. Rascati, Ghadeer K. Dawwas, Maria Stepanova, Steven M. Smith, Debbie L. Wilson, Eric Dietrich and David R. Nelson and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Haesuk Park

103 papers receiving 1.6k citations

Peers

Haesuk Park
Terry McCormack United Kingdom
Hani Tamim Lebanon
Eric S. Orman United States
Kavish R. Patidar United States
Terry McCormack United Kingdom
Haesuk Park
Citations per year, relative to Haesuk Park Haesuk Park (= 1×) peers Terry McCormack

Countries citing papers authored by Haesuk Park

Since Specialization
Citations

This map shows the geographic impact of Haesuk Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haesuk Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haesuk Park more than expected).

Fields of papers citing papers by Haesuk Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haesuk Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haesuk Park. The network helps show where Haesuk Park may publish in the future.

Co-authorship network of co-authors of Haesuk Park

This figure shows the co-authorship network connecting the top 25 collaborators of Haesuk Park. A scholar is included among the top collaborators of Haesuk Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haesuk Park. Haesuk Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Haesuk, et al.. (2025). Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine. JAMA Neurology. 82(2). 132–132. 3 indexed citations
2.
Bhattacharjee, Rakesh, Wei‐Hsuan Lo‐Ciganic, Debbie L. Wilson, et al.. (2025). Narcolepsy and risk of cardiovascular outcomes beyond stimulant use. SLEEP. 48(12). 1 indexed citations
3.
Desai, Raj, et al.. (2024). Comparative Safety of Long‐Acting vs. Short‐Acting Erythropoiesis‐Stimulating Agents Among Patients Undergoing Hemodialysis. Clinical Pharmacology & Therapeutics. 116(1). 217–224. 1 indexed citations
4.
Wang, Wei, et al.. (2023). Association between treatment of hepatitis C virus and risk of cardiovascular disease among insured patients with the virus in the United States. Pharmacoepidemiology and Drug Safety. 32(10). 1142–1151. 2 indexed citations
5.
Smith, Steven M., et al.. (2023). Comparative effectiveness of sodium‐glucose cotransporter‐2 inhibitors among patients with heart failure with preserved ejection fraction. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(10). 1024–1031. 1 indexed citations
6.
Venugopalan, Veena, et al.. (2023). Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population‐based propensity score‐matched cohort study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(9). 883–893. 9 indexed citations
7.
Hernandez‐Con, Pilar, et al.. (2023). Nationwide trends in hospitalization, medical costs, and mortality for asthma after introduction of biologics: A cross-sectional study in the United States. Journal of Managed Care & Specialty Pharmacy. 29(7). 721–731. 4 indexed citations
8.
Dietrich, Eric, et al.. (2023). Comparative effectiveness and safety of direct oral anticoagulants versus warfarin among patients with recurrent venous thromboembolism. Clinical and Translational Science. 16(6). 946–954. 2 indexed citations
9.
Desai, Raj, Haesuk Park, Joshua D. Brown, Rajesh Mohandas, & Steven M. Smith. (2022). Norepinephrine reuptake inhibitors and risk of antihypertensive treatment intensification and major adverse cardiovascular events in patients with stable hypertension and depression. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 42(6). 472–482. 3 indexed citations
10.
Park, Haesuk, Raj Desai, Xinyue Liu, et al.. (2022). Medicare Bundled Payment Policy on Anemia Care, Major Adverse Cardiovascular Events, and Mortality among Adults Undergoing Hemodialysis. Clinical Journal of the American Society of Nephrology. 17(6). 851–860. 4 indexed citations
11.
Desai, Raj, Haesuk Park, Joshua D. Brown, & Steven M. Smith. (2022). Risk of Obstructive Sleep Apnea in Adults with Resistant Hypertension. MDPI (MDPI AG). 1(1). 26–32. 1 indexed citations
12.
Desai, Raj, Haesuk Park, Joshua D. Brown, et al.. (2022). Comparative Safety and Effectiveness of Aldosterone Antagonists Versus Beta-Blockers as Fourth Agents in Patients With Apparent Resistant Hypertension. Hypertension. 79(10). 2305–2315. 8 indexed citations
13.
Park, Haesuk, Wei‐Hsuan Lo‐Ciganic, James L. Huang, et al.. (2022). Evaluation of machine learning algorithms for predicting direct-acting antiviral treatment failure among patients with chronic hepatitis C infection. Scientific Reports. 12(1). 18094–18094. 5 indexed citations
14.
Jiang, Xinyi, Vakaramoko Diaby, Scott Martin Vouri, et al.. (2022). Economic Impact of Universal Hepatitis C Virus Testing for Middle-Aged Adults Who Inject Drugs. American Journal of Preventive Medicine. 64(1). 96–104.
15.
Smith, Steven M., et al.. (2021). Effectiveness of sacubitril/valsartan versus aldosterone antagonists in heart failure with reduced ejection fraction: A retrospective cohort study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 41(9). 710–721.
16.
Dawwas, Ghadeer K., Charles E. Leonard, Scott Martin Vouri, et al.. (2020). Twelve‐year trends in pharmacologic treatment of type 2 diabetes among patients with heart failure in the United States. Diabetes Obesity and Metabolism. 22(4). 705–710. 3 indexed citations
17.
Desai, Raj, Eric Dietrich, Haesuk Park, & Steven M. Smith. (2020). Out-of-Pocket Payment for Ambulatory Blood Pressure Monitoring Among Commercially Insured in the United States. American Journal of Hypertension. 33(11). 999–1002. 6 indexed citations
18.
Dawwas, Ghadeer K., Eric Dietrich, Steven M. Smith, Kyle Davis, & Haesuk Park. (2020). Comparative Effectiveness and Safety of Direct-acting Oral Anticoagulants and Warfarin in Patients with Venous Thromboembolism and Active Cancer: An Observational Analysis. Clinical Therapeutics. 42(9). e161–e176. 4 indexed citations
19.
Dietrich, Eric, et al.. (2019). Reimbursement of ambulatory blood pressure monitoring in the US commercial insurance marketplace. Journal of Clinical Hypertension. 22(1). 6–15. 12 indexed citations
20.
Dawwas, Ghadeer K., Steven M. Smith, & Haesuk Park. (2018). Cardiovascular outcomes of sodium glucose cotransporter‐2 inhibitors in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 21(1). 28–36. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026